Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (2171)	5/15/1998 10:10:00 PM
From: Bradpalm1	Read Replies (3) \| Respond to of 5736

My but it's easy to get everybodies panties in a wad around here. To propose that CCSI is breaking new ground with this "chromatic" technology is ludicrous. "Anemia, hepatitis, tuberculosis, forms of malignancy evaluated through biopsy tissue and different fluid laboratory analysis [sic]" CANNOT be "diagnosed or monitered by the coloration of human skin, tissue or fluids" and never will. This is akin to the same erroneous logic and fraudulent practice of making medical diagnoses based on shifts in a patient's "aura" or chemical analyses of their hair. It appears that CCSI will fit right in here. I suppose if CCSI intends to market the Colormate to naprapaths, chiropractors and clairvoyants they might find some willing and able practitioners. Otherwise, such sophistry will be quickly recognized and unequivocally rejected by the mainstream medical community. Bradpalm1